Jordan Dolin

CareAdvisors is on a mission to improve healthcare equity in the U.S. We are a fast-moving, minority-owned technology company that helps millions of individuals gain rapid access to healthcare and social service benefits by automating the manual enrollment process taken on by healthcare providers. Our technology also enables healthcare organizations to reduce uncompensated care costs and delays in treatment and payments. We are led by a founding team that has over 10 years of experience building community resource directories that address social needs and access to care.

Resonance Medical's otoTune software programs hearing aids to the individual user's needs. We do this by working with device manufacturers to marry our custom artificial intelligence solutions to commercially available hearing aids. We believe that all people deserve access to the best hearing experience possible, and we use advanced AI algorithms to make that possible.

Fibroblast was acquired by Cerner Corporation in October 2020. Fibroblast automates the referral process by empowering providers with an easy to use, end-to-end referral tool. By closing the referral loop, Fibroblasts prevents patient leakage, increasing revenues for fee-for-service organizations and lowering risks for accountable care organizations. Fibroblast delivers a clear, compelling return on investment.

CareAdvisors is on a mission to improve healthcare equity in the U.S. We are a fast-moving, minority-owned technology company that helps millions of individuals gain rapid access to healthcare and social service benefits by automating the manual enrollment process taken on by healthcare providers. Our technology also enables healthcare organizations to reduce uncompensated care costs and delays in treatment and payments. We are led by a founding team that has over 10 years of experience building community resource directories that address social needs and access to care.

Furthur partners with health systems across the country to provide innovative solutions to the largest problems that plague the health system.

Resonance Medical's otoTune software programs hearing aids to the individual user's needs. We do this by working with device manufacturers to marry our custom artificial intelligence solutions to commercially available hearing aids. We believe that all people deserve access to the best hearing experience possible, and we use advanced AI algorithms to make that possible.

Fibroblast was acquired by Cerner Corporation in October 2020. Fibroblast automates the referral process by empowering providers with an easy to use, end-to-end referral tool. By closing the referral loop, Fibroblasts prevents patient leakage, increasing revenues for fee-for-service organizations and lowering risks for accountable care organizations. Fibroblast delivers a clear, compelling return on investment.